SCHEMBL8037852

SCHEMBL8037852

COc1ccc2[nH]c3c(c2c1)CCn1c-3cc(=O)[nH]c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.58
KDM4E B2RXH2 5/20 0.58
CYP1A1 P04798 5/20 0.58
CYP1B1 Q16678 5/20 0.58
MAPT P10636 4/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 2/20 0.58
NPC1 O15118 2/20 0.58
POLB P06746 2/20 0.58
RAB9A P51151 2/20 0.58
KMT2A Q03164 2/20 0.58
NFKB1 P19838 2/20 0.58
ESR1 P03372 1/20 0.58
TP53 P04637 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MTNR1A P48039 1/20 0.55
MTNR1B P49286 1/20 0.55
CYP2D6 P10635 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8025906 0.81 CYP1A2 (0.61) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL14345924 0.81 CYP1A2 (0.63) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL14345763 0.80 CYP1A2 (0.59) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL4704080 0.77 CYP1A2 (0.58) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL14345706 0.75 CYP1A2 (0.53) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL8794276 0.74 KDM4E (0.68) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL878319 0.74 GPR84 (0.50) HTR2AHTR2CHSD17B10DRD2DRD1
SCHEMBL4699371 0.74 CYP1A2 (0.53) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL31402832 0.73 CYP1A1 (1.00) CYP1A2KDM4ECYP1A1CYP1B1MAPT
SCHEMBL14345707 0.73 CYP1A2 (0.65) CYP1A2KDM4ECYP1A1CYP1B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6048868-A CIRCADIAN RHYTHM DISORDERS; SLEEP DISORDERS; ANTIDEPRESSANTS CEMAF (FR) 2000-04-11 US disclosed